Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob G Scott

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2018
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation DoseKamran A Ahmed, Jacob G Scott, John A Arrington, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
Ebiomedicine|August 17, 2019
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementKamran A Ahmed, Casey L Liveringhouse, Matthew N Mills, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Brachytherapy|May 16, 2016
Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcomaArash O Naghavi, Ricardo J Gonzalez, Jacob G Scott, et al.
Scientific Reports|November 7, 2023
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcomaEashwar Somasundaram, Peter M Anderson, Timothy D Smile, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Cancer|April 21, 2012
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderJacob G Scott, Luc Bauchet, Tyler J Fraum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2018
Radiosensitivity of Lung Metastases by Primary Histology and Implications for Stereotactic Body Radiation Therapy Using the Genomically Adjusted Radiation DoseKamran A Ahmed, Jacob G Scott, John A Arrington, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
Ebiomedicine|August 17, 2019
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementKamran A Ahmed, Casey L Liveringhouse, Matthew N Mills, et al.
Clinical Genitourinary Cancer|December 25, 2025
Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing TherapyMonica S Nair, Jessica Scarborough, Chandana A Reddy, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Brachytherapy|May 16, 2016
Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcomaArash O Naghavi, Ricardo J Gonzalez, Jacob G Scott, et al.
Scientific Reports|November 7, 2023
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcomaEashwar Somasundaram, Peter M Anderson, Timothy D Smile, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinomaEmily Ho, Loris De Cecco, Stefano Cavalieri, et al.
Cancer|April 21, 2012
Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or olderJacob G Scott, Luc Bauchet, Tyler J Fraum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 10, 2020
Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLCJacob G Scott, Geoff Sedor, Jessica A Scarborough, et al.
Pageof 13